T1	CHEM 60 93	ácidos grasos PoliinsatuRados ω-3
T2	ANAT 117 123	sérica
#1	AnnotatorNotes T2	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T3	DISO 153 175	Insuficiencia Cardiaca
#2	AnnotatorNotes T3	C0018801; Heart failure; Disease or Syndrome
T4	DISO 183 198	hipoalbuminemia
#3	AnnotatorNotes T4	C0239981; Hypoalbuminemia; Disease or Syndrome
T5	DISO 201 223	actividad inflamatoria
T6	DISO 255 277	Insuficiencia cardiaca
#4	AnnotatorNotes T6	C0018801; Heart failure; Disease or Syndrome
T7	PROC 333 347	hospitalizados
#5	AnnotatorNotes T7	C0019993; Hospitalization; Health Care Activity
T8	DISO 451 466	hipoalbuminemia
#6	AnnotatorNotes T8	C0239981; Hypoalbuminemia; Disease or Syndrome
T9	CHEM 468 476	albúmina
#7	AnnotatorNotes T9	C0001924; Albumins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T10	ANAT 477 483	sérica
#8	AnnotatorNotes T10	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T11	DISO 501 523	actividad inflamatoria
T12	PROC 624 640	ensayos clínicos
#9	AnnotatorNotes T12	C0008976; Clinical Trials; Research Activity
T13	PROC 641 652	Tratamiento
#10	AnnotatorNotes T13	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T14	CHEM 657 667	ácidos ω-3
T15	PROC 695 702	ingreso
#11	AnnotatorNotes T15	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T16	PROC 703 738	Tratamiento percutáneo o quirúrgico
T17	DISO 757 779	insuficiencia cardiaca
#12	AnnotatorNotes T17	C0018801; Heart failure; Disease or Syndrome
T18	PROC 791 798	ingreso
#13	AnnotatorNotes T18	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T19	DISO 821 840	Insuficiencia renal
#14	AnnotatorNotes T19	C0035078; Kidney Failure; Disease or Syndrome | C1565489; Renal Insufficiency; Disease or Syndrome
T20	DISO 854 876	Insuficiencia hepática
#15	AnnotatorNotes T20	C0085605; Liver Failure; Disease or Syndrome | C1306571; Hepatic Insufficiency; Pathologic Function
T21	DISO 895 913	Proceso infeccioso
#16	AnnotatorNotes T21	C0745283; INFECTIOUS PROCESS; Pathologic Function
T22	DISO 921 938	Neoplasia maligna
#17	AnnotatorNotes T22	C0006826; Malignant Neoplasms; Neoplastic Process
T23	PROC 103 135	concentración sérica de albúmina
#18	AnnotatorNotes T23	C0523465; Serum albumin measurement; Laboratory Procedure
T24	ANAT 167 175	Cardiaca
#19	AnnotatorNotes T24	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T25	ANAT 269 277	cardiaca
#20	AnnotatorNotes T25	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T26	DISO 352 354	IC
#21	AnnotatorNotes T26	C0018801; Heart failure; Disease or Syndrome
T27	PROC 468 483	albúmina sérica
#22	AnnotatorNotes T27	C0523465; Serum albumin measurement; Laboratory Procedure
T28	PROC 533 536	PCR
#23	AnnotatorNotes T28	C0201657; C-reactive protein measurement; Laboratory Procedure
T29	ANAT 771 779	cardiaca
#24	AnnotatorNotes T29	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T30	ANAT 835 840	renal
#25	AnnotatorNotes T30	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T31	PROC 844 852	diálisis
#26	AnnotatorNotes T31	C0011946; Dialysis procedure; Therapeutic or Preventive Procedure | C4551529; Renal Dialysis; Therapeutic or Preventive Procedure
T32	ANAT 868 876	hepática
#27	AnnotatorNotes T32	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T33	Date 13 17	2015
T34	LIVB 139 148	pacientes
#28	AnnotatorNotes T34	C0030705; Patients; Patient or Disabled Group
T35	LIVB 304 313	Pacientes
#29	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T36	Age 314 332	mayores de 18 años
T37	Duration 369 376	crónica
#30	AnnotatorNotes T37	C0205191; chronic; Temporal Concept
T39	Date 671 684	el último mes
T40	LIVB 800 819	Mujeres embarazadas
#31	AnnotatorNotes T40	C0033011; Pregnant Women; Population Group
T38	PHYS 808 819	embarazadas
#32	AnnotatorNotes T38	C0032961; Pregnancy; Organism Function
T41	PROC 877 887	Child-Pugh
#33	AnnotatorNotes T41	C3854424; Child-Pugh-Turcotte score; Laboratory Procedure
A1	Status T13 History_of
A2	Status T14 History_of
#34	AnnotatorNotes T5	C0021368; Inflammation; Pathologic Function
#35	AnnotatorNotes T11	C0021368; Inflammation; Pathologic Function
#36	AnnotatorNotes T14	C0015689; omega-3 fatty acids; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T42	Observation 576 601	Pronóstico vital infausto
#37	AnnotatorNotes T42	C0278252; Prognosis bad; Finding
T43	LIVB 602 614	Participante
#38	AnnotatorNotes T43	C4554048; Study Participant; Population Group
R1	Location_of Arg1:T25 Arg2:T6	
T44	Observation 602 640	Participante en otros ensayos clínicos
R3	Location_of Arg1:T10 Arg2:T27	
T45	Observation 46 52	Efecto
#39	AnnotatorNotes T45	C1518681; Outcome of Therapy; Finding (?)
R4	Causes Arg1:T1 Arg2:T45	
R5	Location_of Arg1:T2 Arg2:T23	
R6	Experiences Arg1:T34 Arg2:T23	
R7	Experiences Arg1:T34 Arg2:T3	
R8	Location_of Arg1:T24 Arg2:T3	
R9	Experiences Arg1:T34 Arg2:T1	
R10	Experiences Arg1:T34 Arg2:T45	
T46	Quantifier_or_Qualifier 176 181	Aguda
#40	AnnotatorNotes T46	C0439557; Acute phase; Temporal Concept
R11	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T46	
T47	Quantifier_or_Qualifier 355 360	aguda
#41	AnnotatorNotes T47	C0439557; Acute phase; Temporal Concept
R12	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T47	
T48	Quantifier_or_Qualifier 914 919	agudo
#42	AnnotatorNotes T48	C0439557; Acute phase; Temporal Concept
T49	Quantifier_or_Qualifier 939 945	activa
#43	AnnotatorNotes T49	C0679217; Active State; Idea or Concept
R13	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T49	
R14	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T48	
R15	Location_of Arg1:T32 Arg2:T20	
R16	Location_of Arg1:T30 Arg2:T19	
T50	Result_or_Value 888 893	B o C
R17	Has_Result_or_Value Arg1:T41 Arg2:T50	
R18	Experiences Arg1:T40 Arg2:T38	
R19	Location_of Arg1:T29 Arg2:T17	
R20	Overlap Arg1:T16 Arg2:T18	
R21	Used_for Arg1:T14 Arg2:T13	
R22	Overlap Arg1:T13 Arg2:T39	
R23	Before Arg1:T13 Arg2:T15	
T51	Result_or_Value 484 493	≤3,4 g/dl
R24	Has_Result_or_Value Arg1:T27 Arg2:T51	
T52	Result_or_Value 537 547	>2,5 mg/dl
R25	Has_Result_or_Value Arg1:T28 Arg2:T52	
T53	Quantifier_or_Qualifier 524 531	elevada
#44	AnnotatorNotes T53	C0205250; High; Qualitative Concept
R26	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T53	
T54	Quantifier_or_Qualifier 224 231	elevada
#45	AnnotatorNotes T54	C0205250; High; Qualitative Concept
R27	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T54	
R28	Experiences Arg1:T34 Arg2:T5	
R29	Experiences Arg1:T34 Arg2:T4	
R30	Has_Age Arg1:T35 Arg2:T36	
R31	Experiences Arg1:T35 Arg2:T7	
R32	Experiences Arg1:T35 Arg2:T26	
T55	Quantifier_or_Qualifier 377 390	descompensada
#46	AnnotatorNotes T55	C0205434; Decompensated; Qualitative Concept
R33	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T55	
T56	Observation 396 411	nueva aparición
#47	AnnotatorNotes T56	C0746890; new onset; Finding
R34	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T56	
R35	Has_Duration_or_Interval Arg1:T26 Arg2:T37	
R36	Overlap Arg1:T26 Arg2:T8	
R37	Experiences Arg1:T35 Arg2:T8	
R38	Experiences Arg1:T35 Arg2:T11	
R39	Overlap Arg1:T8 Arg2:T11	
R40	Overlap Arg1:T26 Arg2:T11	
R2	Experiences Arg1:T35 Arg2:T28	
#48	AnnotatorNotes T1	C0015689; omega-3 fatty acids; Pharmacologic Substance
A3	Experiencer T34 Patient
A4	Experiencer T35 Patient
A5	Experiencer T43 Patient
A6	Experiencer T40 Patient
